IS4783A - 1,4 -Díhýdrópýridín efnasambönd sem mótlyf gegn kínínseinkun - Google Patents
1,4 -Díhýdrópýridín efnasambönd sem mótlyf gegn kínínseinkunInfo
- Publication number
- IS4783A IS4783A IS4783A IS4783A IS4783A IS 4783 A IS4783 A IS 4783A IS 4783 A IS4783 A IS 4783A IS 4783 A IS4783 A IS 4783A IS 4783 A IS4783 A IS 4783A
- Authority
- IS
- Iceland
- Prior art keywords
- quinine
- antagonists
- delays
- dihydropyridine compounds
- dihydropyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9600132 | 1996-02-19 | ||
| PCT/IB1997/000058 WO1997030048A1 (en) | 1996-02-19 | 1997-01-27 | 1,4-dihydropyridine compounds as bradykinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4783A true IS4783A (is) | 1998-06-25 |
Family
ID=11004406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4783A IS4783A (is) | 1996-02-19 | 1998-06-25 | 1,4 -Díhýdrópýridín efnasambönd sem mótlyf gegn kínínseinkun |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6131226A (is) |
| EP (1) | EP0882044B1 (is) |
| JP (1) | JP3167335B2 (is) |
| KR (1) | KR19990082678A (is) |
| CN (1) | CN1211251A (is) |
| AR (1) | AR005841A1 (is) |
| AT (1) | ATE220676T1 (is) |
| AU (1) | AU1396497A (is) |
| BG (1) | BG102678A (is) |
| BR (1) | BR9707568A (is) |
| CA (1) | CA2245857C (is) |
| CO (1) | CO4650041A1 (is) |
| CZ (1) | CZ258698A3 (is) |
| DE (1) | DE69714019T2 (is) |
| DK (1) | DK0882044T3 (is) |
| ES (1) | ES2177921T3 (is) |
| HN (1) | HN1997000013A (is) |
| HR (1) | HRP970094A2 (is) |
| HU (1) | HUP9902810A3 (is) |
| ID (1) | ID16434A (is) |
| IL (1) | IL124867A0 (is) |
| IS (1) | IS4783A (is) |
| MA (1) | MA26419A1 (is) |
| NO (1) | NO983776D0 (is) |
| NZ (1) | NZ325455A (is) |
| OA (1) | OA10712A (is) |
| PE (1) | PE36298A1 (is) |
| PL (1) | PL328514A1 (is) |
| PT (1) | PT882044E (is) |
| SI (1) | SI0882044T1 (is) |
| TN (1) | TNSN97037A1 (is) |
| TR (1) | TR199801593T2 (is) |
| WO (1) | WO1997030048A1 (is) |
| ZA (1) | ZA971357B (is) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11106375A (ja) * | 1997-08-18 | 1999-04-20 | Pfizer Pharmaceut Inc | ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物 |
| US6653313B2 (en) * | 2000-08-10 | 2003-11-25 | Warner-Lambert Company Llc | 1,4-dihydropyridine compounds as bradykinin antagonists |
| GB0427281D0 (en) * | 2004-12-14 | 2005-01-12 | 3M Innovative Properties Co | Methods of providing medicinal metal components having through holes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120750A (en) * | 1989-01-17 | 1992-06-09 | Synphar Laboratories, Inc. | Generation of 1,4-dihydropyridine derivatives |
| WO1996006083A1 (en) * | 1994-08-24 | 1996-02-29 | Pfizer Pharmaceuticals Inc. | 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| MX9701245A (es) * | 1996-02-19 | 1998-04-30 | Pfizer | Compuestos de 1,4 dihidropiridina. |
-
1996
- 1996-02-18 TN TNTNSN97037A patent/TNSN97037A1/fr unknown
-
1997
- 1997-01-27 JP JP52913897A patent/JP3167335B2/ja not_active Expired - Fee Related
- 1997-01-27 EP EP97900401A patent/EP0882044B1/en not_active Expired - Lifetime
- 1997-01-27 DK DK97900401T patent/DK0882044T3/da active
- 1997-01-27 WO PCT/IB1997/000058 patent/WO1997030048A1/en active IP Right Grant
- 1997-01-27 AU AU13964/97A patent/AU1396497A/en not_active Abandoned
- 1997-01-27 HU HU9902810A patent/HUP9902810A3/hu unknown
- 1997-01-27 KR KR1019980706424A patent/KR19990082678A/ko not_active Application Discontinuation
- 1997-01-27 CA CA002245857A patent/CA2245857C/en not_active Expired - Fee Related
- 1997-01-27 ES ES97900401T patent/ES2177921T3/es not_active Expired - Lifetime
- 1997-01-27 TR TR1998/01593T patent/TR199801593T2/xx unknown
- 1997-01-27 SI SI9730361T patent/SI0882044T1/xx unknown
- 1997-01-27 NZ NZ325455A patent/NZ325455A/xx unknown
- 1997-01-27 CZ CZ982586A patent/CZ258698A3/cs unknown
- 1997-01-27 AT AT97900401T patent/ATE220676T1/de not_active IP Right Cessation
- 1997-01-27 HN HN1997000013A patent/HN1997000013A/es unknown
- 1997-01-27 IL IL12486797A patent/IL124867A0/xx unknown
- 1997-01-27 CN CN97192240A patent/CN1211251A/zh active Pending
- 1997-01-27 DE DE69714019T patent/DE69714019T2/de not_active Expired - Fee Related
- 1997-01-27 PL PL97328514A patent/PL328514A1/xx unknown
- 1997-01-27 BR BR9707568A patent/BR9707568A/pt active Search and Examination
- 1997-01-27 PT PT97900401T patent/PT882044E/pt unknown
- 1997-01-27 US US09/125,137 patent/US6131226A/en not_active Expired - Fee Related
- 1997-02-10 PE PE1997000085A patent/PE36298A1/es not_active Application Discontinuation
- 1997-02-13 CO CO97007547A patent/CO4650041A1/es unknown
- 1997-02-17 AR ARP970100614A patent/AR005841A1/es unknown
- 1997-02-18 MA MA24498A patent/MA26419A1/fr unknown
- 1997-02-18 HR HRPCT/IB96/00132A patent/HRP970094A2/xx not_active Application Discontinuation
- 1997-02-18 ZA ZA971357A patent/ZA971357B/xx unknown
- 1997-02-18 ID IDP970467A patent/ID16434A/id unknown
-
1998
- 1998-06-25 IS IS4783A patent/IS4783A/is unknown
- 1998-07-10 OA OA9800111A patent/OA10712A/en unknown
- 1998-08-10 BG BG102678A patent/BG102678A/xx unknown
- 1998-08-18 NO NO983776A patent/NO983776D0/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5462A (is) | Setin 4-amínó-þíazol-2-yl efnasambönd sem hindrarfyrir CDK | |
| IS5941A (is) | Píperidín sem CCR5 stillar | |
| FI965202A0 (fi) | Farmaseuttiset takriinikoostumukset | |
| PT925298E (pt) | Derivados 6,6-hetero-biciclicos substituidos | |
| ID18003A (id) | Antagonis muskarinik | |
| BR9609857A (pt) | Composições de paroxetina de liberação controlada | |
| ID28026A (id) | Senyawa-senyawa 1,2,3,4-tetrahidrokuinolina-tersubstitusi-4-karboksiamino-2 sebagai penghambat-penghambat cetp | |
| DE19581637T1 (de) | Multifunktionelle, biologisch dispergierende/biozide Zusammensetzungen | |
| ID16251A (id) | Komposisi-komposisi pembasmi kuman | |
| DE69708866D1 (de) | Mikroverkapselte zusammensetzungen | |
| IS4953A (is) | Tetrahýdrókínólín afleiður sem EAA mótlyf | |
| BR9708576A (pt) | Composicões detergentes compreendendo composto profragráncia | |
| DE69719442D1 (de) | Frisierschaum-Zusammensetzungen | |
| IS4760A (is) | 3-Azetidínýlalkýlpíperidín eða -pýrrólidín sem mótlyf gegn takýkínini | |
| IS4677A (is) | Tetrahýdrókínólín sem NMDA mótlyf | |
| FI960726A (fi) | Bitumikoostumus | |
| NO993460D0 (no) | Paroxetine-preparater | |
| ID27845A (id) | Turunan tetrahidrokuilina sebagai antagonis glisilina | |
| BR9711977A (pt) | Composi-{es biocidas | |
| NO972584D0 (no) | Smaksmodifiserende sammensetning | |
| HK1015363A1 (en) | Compounds analogous to thalidomide from the class comprising piperidine-2, 6-diones | |
| DE69613847D1 (de) | Bituminöse zusammensetzungen | |
| IS4783A (is) | 1,4 -Díhýdrópýridín efnasambönd sem mótlyf gegn kínínseinkun | |
| IS5269A (is) | Fjórgreind ammóníum efnasambönd sem mótverkandi efni gegn kínínhröðun | |
| MA23731A1 (fr) | Compositions detegentes |